Pharming Group

Rare disease patients lack effective therapies, particularly in protein deficiencies requiring replacement treatments.

It develops and commercializes protein replacement therapies and precision medicines for underserved rare diseases.

Patients with rare diseases and the healthcare providers and hospitals that treat them.